How often should we monitor for reliable detection of atrial fibrillation recurrence? Efficiency considerations and implications for study design by Charitos, Efstratios I et al.
How Often Should We Monitor for Reliable Detection of
Atrial Fibrillation Recurrence? Efficiency Considerations
and Implications for Study Design
Efstratios I. Charitos1*, Paul D. Ziegler2, Ulrich Stierle1, Derek R. Robinson3, Bernhard Graf1,
Hans-Hinrich Sievers1, Thorsten Hanke1
1Department of Cardiac and Thoracic Vascular Surgery, University of Luebeck, Luebeck, Germany, 2Medtronic Inc., Minneapolis, Minnesota, United States of America,
3Department of Mathematics, School of Mathematical and Physical Sciences, University of Sussex, Brighton, United Kingdom
Abstract
Objective: Although atrial fibrillation (AF) recurrence is unpredictable in terms of onset and duration, current intermittent
rhythm monitoring (IRM) diagnostic modalities are short-termed and discontinuous. The aim of the present study was to
investigate the necessary IRM frequency required to reliably detect recurrence of various AF recurrence patterns.
Methods: The rhythm histories of 647 patients (mean AF burden: 12622% of monitored time; 687 patient-years) with
implantable continuous monitoring devices were reconstructed and analyzed. With the use of computationally intensive
simulation, we evaluated the necessary IRM frequency to reliably detect AF recurrence of various AF phenotypes using IRM
of various durations.
Results: The IRM frequency required for reliable AF detection depends on the amount and temporal aggregation of the AF
recurrence (p,0.0001) as well as the duration of the IRM (p,0.001). Reliable detection (.95% sensitivity) of AF recurrence
required higher IRM frequencies (.12 24-hour; .6 7-day; .4 14-day; .3 30-day IRM per year; p,0.0001) than currently
recommended. Lower IRM frequencies will under-detect AF recurrence and introduce significant bias in the evaluation of
therapeutic interventions. More frequent but of shorter duration, IRMs (24-hour) are significantly more time effective
(sensitivity per monitored time) than a fewer number of longer IRM durations (p,0.0001).
Conclusions: Reliable AF recurrence detection requires higher IRM frequencies than currently recommended. Current IRM
frequency recommendations will fail to diagnose a significant proportion of patients. Shorter duration but more frequent
IRM strategies are significantly more efficient than longer IRM durations.
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Introduction
The diagnosis of atrial fibrillation (AF) and the detection of its
recurrence after therapeutic interventions are typically performed
by electrocardiographic documentation. Reliable and accurate
detection of AF recurrence is challenging since its rhythm
documentation is discontinuous, whereas the recurrence of AF is
often unpredictable [1] and may or may not be accompanied by
symptoms [2,3]. Accurate AF recurrence detection is of impor-
tance not only for patient management, but also for the scientific,
evidence-based evaluation of therapeutic interventions targeting
AF recurrence. Under-detection of AF recurrence introduces a
significant external bias, distorts the success rates, and thus affects
the scientific evaluation of therapeutic interventions.
Implantable, subcutaneous, leadless as well as intra-cardiac
continuous monitoring (CM) devices can reliably detect AF [4–8].
However, due to cost considerations and invasiveness of CM,
intermittent rhythm monitoring strategies (IRM) of various
durations and frequencies are still the most widely used diagnostic
modalities for patient monitoring and reporting outcomes. Several
groups have compared the efficiency of various IRM strategies
with CM devices [5,6,9–11]. It is now a general consensus that
IRM will fail to detect AF recurrence, albeit in a percentage of
patients that is unknown and difficult to prospectively estimate
[5,6,12,13]. The sensitivity of IRM has been reported to range
between 30% and 70% for patients with paroxysmal AF
[5,6,12,13]. Our group has previously shown that the success rate
of any IRM strategy depends on four factors: the quantitative and
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temporal characteristics of atrial fibrillation recurrence as well as
the frequency and duration of the IRMs performed to detect AF
recurrence [5].
The aim of the present manuscript is to investigate the IRM
frequencies required to reliably (at least 80% or 95% probability)
detect AF recurrence of various AF phenotypes and with various
IRM durations. We discuss efficiency considerations as well as
implications for clinical trial design.
Methods
Data acquired from 647 patients monitored with a CM device
(Reveal XT cardiac monitor, n = 73; AT500 pacemaker, n= 574;
Medtronic, Inc., Minneapolis, MN, USA) were analyzed. Demo-
graphics and detailed patient characteristics are displayed in
Table 1. All patients provided written informed consent for data
collection and use. The study has been approved by the local
(University of Lu¨beck) ethics committee (Clinical Trial Regis-
tration URL: http://www.clinicaltrials.gov unique identifier:
NCT00806689). The complete rhythm history of each patient was
reconstructed from the CM data. AF burden was defined as the
proportion of the total monitored time that a patient was in AF.
For example, a patient that spends 50% of the time in AF, has an
AF burden of 0.5. However, the AF burden alone cannot describe
the temporal characteristics of AF recurrence. For example in
Figure 1A and 1B, the patients A and B have the same overall
amount of AF (AF burden = 0.173) but this AF burden is
distributed differently throughout the observation period. To
describe the distribution pattern of the AF recurrence we
previously proposed the AF density [5,14], as a quantitative
measure of the temporal aggregation of the AF burden consisting
of values between 0 (AF burden evenly spread over the observation
time) and 1 (maximum possible AF burden aggregation, i.e. the
complete AF burden occurs as one continuous episode of AF).
Details on the calculation of the AF density have been presented in
detail previously [5,14]. In brief, for each patient, the time course
of the AF burden development was analyzed throughout the
monitored period (Figure 1A and 1B, for patients A and B
respectively) and the minimum contiguous monitored time required for
the development of each proportion of the patient’s total observed
AF burden throughout the monitored period was calculated and
evaluated for the overall observation period (blue or red dotted
line, Figure 1E and 1F, respectively). Patient A (Figure 1A)
develops 10%, 30%, 50%, 70% and 90% of his total observed
burden in 2%, 5%, 9%, 13% and 21% of the total monitored
time, respectively (blue dotted line, Figure 1E), and most of the
AF recurrence and burden development occurs between days 30
and 80. This information on the temporal burden development of
patient A is displayed in Figure 1E. In contrast, patient B
(Figure 1B) develops 10%, 30%, 50%, 70% and 90% of his total
observed burden in 6%, 24%, 48%, 71% and 89% of the total
monitored time respectively, since the total burden is spread over
more days and as such each day contributes less to the total
burden development. This information on the temporal burden
development of patient B is displayed in Figure 1F. The black
diagonal line (Figure 1E and 1F) represent the hypothetical
development of the patient’s AF burden if this burden had been
uniformly distributed over the monitored time (same AF duration
every day throughout the observation period, uniform burden,
Figure 1C and 1G). The green dotted line (Figure 1H)
represents the burden development of a hypothetical patient in
which the AF burden (equal in amount to that of patient A and B)
occurs as one single continuous episode (maximum density,
Figure 1D).
For the calculation of the AF density as a measure of temporal
AF burden aggregation, the patient’s complete rhythm history is
scanned and the minimum contiguous time required to develop each
proportion p of the patients total burden b is calculated (red and
blue dotted line, Figure 1E and 1F). We define as AF density, the
ratio of the cumulative deviation of the patient’s actual burden
development (blue or red area, Figure 1E and 1F, respectively)
from the hypothetical uniform burden development (black
diagonal line, Figure 1E and 1F), to that of the hypothetical
maximum possible burden aggregation for that level of burden
from the hypothetical uniform burden development (the complete
burden as one continuous episode, green area, Figure 1H). The
black diagonal (Figures 1E, 1F, 1G, 1H) represents a
hypothetical uniform burden aggregation (Figure 1C).
For the numerical evaluation of the AF density we define: For a
patient with a total AF burden b (expressed as the proportion of
the observation time the patient is in AF), who is monitored for
time T, we denote the minimum contiguous monitored time
throughout the monitored period T required for the development
of a proportion p of the patient’s total observed burden (b) as
T(p; b). This time, expressed as the proportion of the total
observed time T, is
F(p; b)~
T(p; b)
T
:
Figures such as 1E and 1F are plots of p against F(p;b) for 0#p#1.
The cumulative deviation of the patient’s actual burden
development from the hypothetical uniform burden development
(black diagonal line, Figure 1E, 1F, 1G, 1H) can be evaluated as
ð1
0
F (p; b){pj jdp
and is equal to the shaded area (blue shaded area for patient
A, Figure 1E; red shaded area for patient B; Figure 1F).
For the hypothetical patient with maximum temporal aggregation
of burden b (the complete burden as one continuous AF episode)
the cumulative deviation of this patient’s burden development
(green line, Figure 1H) from the hypothetical uniform burden
development (black diagonal line, Figure 1G) is evaluated as
1{b
2
and is equal to the green shaded area (Figure 1H). AF density for
patients A and B is then the ratio of the blue or red areas
respectively, to the green shaded area and is defined as:
AFdensity~2 
Ð1
0
F (p; b){pj jdp
1{b
:
The AF density as the ratio of the above mentioned areas is
therefore a dimensionless quantity and assumes values between 0
and 1, with values close to 0 denoting low burden aggregation (AF
burden evenly spread throughout the monitored period,
Figure 1B & 1F as well as Figure 1C & 1G), whereas values
close to 1 denote maximal burden temporal aggregation (the
complete AF burden occurring as a single continuous episode or
‘‘a block of AF’’, Figure 1A & 1E as well as Figure 1D & 1H).
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After reconstruction of each patient’s complete rhythm history,
we used computationally intensive simulation to repeatedly
simulate IRM of various durations (1, 7, 14, 30 days) and
frequencies (1, 2, 3, …,12 as appropriate) in every patient. The
stochastic process of the simulation procedure was the following:
After reconstructing the rhythm history of every patient j,
monitored for a total of g days, we defined the sample space
Vkj = {1, 2, …, g2k+1} to be the set of possible days that a k-day
intermittent monitoring session could be started (for k=1, 2, 3, …,
30). A k-day monitoring session starting on day i M Vkj therefore
included the following associated monitored days: {i, i+1, …,
i+k21}. To simulate a strategy of n independent k-day monitor-
ings of patient j, n elements were selected at random from Vkj,
except that elements were rejected if their monitored days
intersected with the monitored days of previously selected
elements. This was performed for all patients of the study
population, for monitoring durations of k={1,2,3…,30} days,
and for strategies of n= {1, 2, 3, …, 12} monitorings per year,
where appropriate. In every simulated IRM, AF was deemed to
have been successfully identified if it was observed on at least one
of the monitored days. The simulations were performed in all
patients, for every IRM strategy (all IRM frequencies and IRM
durations) sufficient times (.105) to allow stabilization of the
inferred probability of AF burden recurrence.
In order to mimic the typical timely follow-up strategy
employed in clinical trials, the simulation worked as follows: First,
the ‘‘first day’’ of the first monitoring period (IRM) was chosen at
random, and then the subsequent k-1 days were counted to make a
k day monitoring period (IRM). An example is illustrated in
Figure 2 for the simulation of 7-day monitoring. The first
sampled day happened to be on day 179, therefore the 7-day IRM
would be on days 179–185. Any future sampling that includes days
173–191 will be rejected (i.e., any 7-day IRM starting on these
days would intersect with the sampled IRM on days 179–185).
Second, the simulation procedure then scans the total observa-
tion period of the patient and at even intervals (based on the pre-
specified IRM frequency) attaches weights at the following days:
first sampled day6k*(365/sampling strategy frequency), where
k = {1,2,3,4, …, sampling strategy frequency}. In the example
shown in Figure 2, the algorithm attaches higher sampling
weights at days 9, 99, 279 and 370. Gaussian smoothing was used
to construct a smoothed sampling weight curve (Figure 2) such
that the zeniths have about 3 times higher probability to be
sampled than the nadirs. Attaching higher sampling probability
weights at even intervals mimics the follow-up strategy of clinical
Figure 1. Four examples of different temporal aggregation for the same AF burden (0.173). After reconstruction of the rhythm history
(upper panels), the minimum time required for the development of each proportion of the patient’s total observed AF burden throughout the
monitored period is evaluated (lower panels, dotted lines). AF density is defined as the ratio of the cumulative deviation of the patient’s actual
burden development (blue or red area) from the uniform burden development (black diagonal line, lower panels and Uniform Burden), to that of the
maximum possible burden aggregation for that level of burden (the complete burden as one continuous episode, green area). The black diagonal
(lower panels) represents a hypothetical uniform burden aggregation (Uniform Burden). Adapted from [14].
doi:10.1371/journal.pone.0089022.g001
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trials, while also simultaneously allowing some randomness (just as
in real life follow-up examinations, patients often are seen slightly
before or after their nominal follow-update). Thereafter the
simulation proceeds with sampling from the weighted sample
space. For every patient and for every IRM duration and
frequency, sufficient simulations were carried out (.105) to
estimate the probability of AF detection accurately. The required
IRM frequency to achieve at least 80% (f80%) and at least 95%
(f95%) probability of AF detection, could then be determined for
each patient and IRM duration. All simulated IRM was of the
continuous recording type and patient compliance was assumed to
be 100%.
Response surface models were used to evaluate the dependency
of the probability of AF detection (f95%, f80%) on AF burden and
density. These models are of the form:
y~b0z
X
i
bixiz
X
i
biix
2
iz
X
i
X
jvi
bijxixjze
In modeling f95% and f80% it was found appropriate to use its
natural logarithm, so that y = ln(f95% or f80%), x1 =AF burden,
x2 =AF density. Separate models were used for the most
commonly used IRM durations (24 hours, 7 days, 14 days and
30 days). Backwards stepwise elimination was used to derive the
final models which are presented in Table 2.
All simulations were performed on multiple parallel AWS
(Amazon Web Services, WA, USA) Elastic Cloud Computing high
performance compute clusters (cc8.xlarge) running Ubuntu Server
Linux 12.04.01 LTS (AWS Cluster Instances). A primer on the
infrastructure and use of high performance cloud computing for
biomedical research and simulation studies has been published
elsewhere [15,16]. The statistical analyses and simulations were
performed with R version 2.15.3 [17]. The P values of 2-sided tests
are reported.
Results
Estimation of the probability of AF detection with an
intermittent monitoring strategy
For a single IRM of n-days duration and for any given AF
burden b, observed during any sufficiently large time frame t
(t..n), the probability of successful AF detection ranges between
>b and 1. Its exact value within the range [>b,1] depends on the
temporal aggregation of the AF recurrence [5]. If the AF occurs as
one episode, the probability of AF detection is >b (Figure 3,
Patient B), whereas if the AF recurrence is uniformly distributed
throughout the observation time the probability of AF recurrence
detection is 1 (Figure 3, Patient A). We have shown previously
that the AF density can efficiently describe the temporal
aggregation and thus the recurrence pattern of the AF burden
[5,14]. For the IRM durations examined in the present work, AF
burden and AF density had a significant effect in determining the
probability of successful AF detection with a single random IRM
(for all IRM durations: p,0.0001 for AF burden and AF density,
R2 .85%). Using computationally intensive simulation, similar
graphs and relationships can be obtained with IRMs of any
duration and/or frequency.
Figure 3 left panel shows the effect of AF burden and density
on the probability of AF detection of a single 24 hour IRM. Both
Patient A and B have been continuously monitored for 364 days
and both have an AF burden of 0.2, however the temporal AF
burden distribution differs (Figure 3 right panel). Patient A has
a low temporal AF aggregation (AF spread throughout the
observation period with an AF density of 0.28), whereas patient B
has the majority of the AF burden developed only between day 50
and 114 (AF density = 0.98). Due to the high temporal aggregation
Table 1.
Total %
Male 376 58.1
Age 68.9612.3
Follow up (mean ± sd, range; years) 1.160.4, 0.1–3.7
History of Atrial Arrhythmia
Atrial Tachycardia 114 17.6
Atrial Flutter 176 27.2
Paroxysmal AF 475 73.4
Persistent AF 32 4.9
Long lasting persistent AF 35 5.4
History of Cardioversion 18 2.8
Cardiovascular History
Ischemic Heart Disease 99 15.3
Coronary Artery Disease 220 34.0
Cardiomyopathy 64 9.9
Hypertension 405 62.6
History of ablation for AF
Cox-Maze III 17 2.6
Left sided only 53 8.2
AV Node Ablation 28 4.3
Other 71 11.0
History of Cardiac Surgery
CABG 113 17.5
MVR 45 7.0
AVR 41 6.3
TVR 7 1.1
Asc. Aorta Replacement 9 1.4
PVR 1 0.2
NYHA Class
I 331 51.2
II 234 36.2
III 67 10.4
IV 3 0.5
Pacing Indication
AV-Block 85 13.1
Sinus node dysfunction 397 61.4
Other 41 6.3
Arrhythmia related medication
Class I 89 13.8
Class III 251 38.8
Beta-Blocker 212 32.8
Calcium Channel Blocker 56 8.7
Digoxin 144 22.3
Patient demographics: AF: atrial fibrillation; AV: atrioventricular; CABG: coronary
artery bypass grafting; MVR: mitral valve replacement/repair; AVR: aortic valve
replacement/repair; TVR: tricuspid valve replacement/repair; PVR: pulmonary
valve replacement; NYHA: New York Heart Association.
doi:10.1371/journal.pone.0089022.t001
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(increased AF density), the probability that a random 24-hour
IRM will detect AF recurrence in patient B is 0.23. In contrast, in
patient A, AF recurrences are distributed over almost every day of
the entire monitored time and thus the probability of AF
recurrence detection is much higher, 0.9.
Frequency of IRM required to reliably detect AF
recurrence according to AF burden and AF density
Since the probability of successful AF identification depends on
the AF characteristics (AF burden and AF density), inferences can
be drawn regarding how many times IRM should be performed in
order to reliably (probability .95%) detect AF recurrence.
Table 2 presents the results of the regression analyses, of the
AF characteristics on the required IRM frequency to achieve
.95% probability for AF detection. These results are more clearly
visualized in Figures 4–7 which present the frequency of IRM
required to detect AF recurrence with 80% and 95% probability
as a function of the AF characteristics (AF burden and AF density).
For all IRM durations, the IRM frequency required to detect AF
recurrence with a 95% probability increases as the AF burden
decreases and as the AF density increases (AF burden less spread
throughout the observation time) (Table 2).
Figures 4–7 indicate that strategies of twelve 24-hour, six 7-day,
four 14-day and three 30-day per year will be able to detect on
average 96%, 95%, 91%, 90% of all AF recurrence phenotypes (AF
burden/AF density combinations) with a probability of 95% (area
below the respective IRM frequency dotted lines, Figure 4–7). In
our patient population, which had a mean burden of 0.1260.22, the
above mentioned IRM strategies would succeed in diagnosing AF
recurrence in 83%, 77%, 70%, 68% of these patients (dots below
the respective IRM frequency lines, Figure 4–7). Patients with even
lower burdens and/or higher densities (dots above the respective
IRM frequency lines, Figure 4–7) will require more aggressive
monitoring strategies which increases the likelihood of poor
compliance.
Time efficiency as a function of AF burden and AF
density
The time efficiency (sensitivity obtained per day of IRM) was
dependent on both AF characteristics (AF burden and AF density)
and IRM characteristics (IRM duration and IRM frequency;
p,0.001 for all). For the same overall IRM duration, the 24-hour
IRM results in higher sensitivity per unit of monitored time than
prolonged IRM durations (Figure 8). As Figures 4–7 show,
strategies of twelve 24-hour, six 7-day, four 14-day and three 30-
day per year will be able to detect on average 96%, 95%, 91% and
90% of all AF recurrence phenotypes (AF burden/AF density
combinations) with a probability of 95%, or 83%, 77%, 70% and
68% of our patient population, respectively. However to obtain
these sensitivities, these strategies would require a total monitoring
time of 12, 42, 56, and 90 days for the 24-hour, 7-day, 14-day and
30-day IRM, respectively.
Discussion
Currently the most widely used diagnostic modality for the
detection of AF recurrence is IRM. However, in contrast to other
diagnostic examinations in medicine which are required to have
the highest possible sensitivity and specificity, the absence of non-
invasive and cost efficient alternatives has made IRM a standard
for AF recurrence detection and rhythm follow-up even though its
sensitivity as a diagnostic test is strikingly low [5,6,11–13,18].
Figure 2. Illustration of the simulation procedure: Initially, the ‘‘first day’’ of the first monitoring period (IRM) was chosen at
random, and then the subsequent k-1 days were counted to make a k day monitoring period (IRM). In this example the 7-day IRM
would be on days 179–185. Any future sampling that includes days 173–191 will be rejected (any 7 day IRM starting on these days would intersect
with the sampled IRM on days 179–185). Second, the simulation procedure scans the total observation period of the patient and at even intervals
(based on the pre-specified IRM frequency) attaches weights at the following days: first sampled day6k*(365/sampling strategy frequency), where
k = {1,2,3,4, …, sampling strategy frequency}. In this example, the algorithm attaches higher sampling weights at days 9, 99, 279, 370. Gaussian
smoothing was used to construct a smoothed sampling weight curve such that the zeniths have about 3 times higher probability to be sampled than
the nadirs. Attaching higher sampling probability weights at even intervals mimics the follow-up strategy of clinical trials, while also simultaneously
allowing some randomness (just as in real life follow-up examinations, patients often are seen slightly before or after their nominal follow-update).
Thereafter the simulation proceeds with sampling from the weighted sample space.
doi:10.1371/journal.pone.0089022.g002
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Since the identification of AF recurrence is seminal importance for
accurate patient management and for the scientific evaluation of
therapeutic AF interventions, we sought to determine the
frequency of IRMs required to identify AF recurrence with 80%
and 95% probability.
Determining the probability of AF detection
Our results indicate that the quantitative AF characteristics (AF
burden and AF density) as well as the IRM strategy characteristics
(IRM frequency and IRM duration) can determine the probability
of successful AF identification using IRM. Figure 3 Left Panel
shows the interrelation between AF burden and AF density in
determining the probability of AF identification with a single
random 24-hour IRM. Similar relationships can be obtained for
other IRM durations as well as IRM frequencies. Our analyses
show that the probability of AF identification increases as the AF
density decreases (AF recurrence spread more evenly throughout
the observation time) and/or AF burden increases. The influence
of AF density on the AF detection probability for any IRM is of
critical importance at lower burdens (,0.5) and diminishes
progressively at higher (.0.5) AF burdens (Figure 3 Left Panel).
Current guidelines and consensus statements address the need
for intermittent monitoring for the detection of AF recurrence
[12,13,18]. Although most recommendations suggest an IRM
monitoring strategy between two and four 24-hour IRM per year
for the detection of AF recurrence, most statements simultaneously
note that these strategies have a limited sensitivity and a significant
proportion of patients with AF recurrence will not be detected. A
speculative estimate is that IRM strategies may detect up to 70%
of patients with AF recurrence and may have a negative predictive
value of up to 50% [12,13,18]. However these estimates, which
stem from published studies, cannot be reliably transferred to
other studies or other prospectively recruited populations. Our
results point out that the sensitivity and thus the required
frequency to reliably detect AF recurrence, depends largely on
the AF and IRM characteristics and may deviate from the above
Table 2. Regression (response surface models) of the AF
characteristics (AF burden, AF density) on the IRM frequencies
required to achieve 95% probability of AF recurrence
detection.
Factor
Coefficient
(mean±SE) p
24h IRM model (R2 = 70.4%)
Intercept 22.0160.08 ,0.001
AF Burden 24.8260.40 ,0.001
AF Density 1.360.11 ,0.001
AF Burden2 2.1360.42 ,0.001
7d IRM model (R2 = 70.2%)
Intercept 0.8860.07 ,0.001
AF Burden 25.0960.35 ,0.001
AF Density 1.9060.10 ,0.001
AF Burden2 3.0360.39 ,0.001
14d IRM model (R2 = 69.4%)
Intercept 0.5260.06 ,0.001
AF Burden 24.4060.32 ,0.001
AF Density 1.8960.10 ,0.001
AF Burden2 2.6760.37 ,0.001
30d IRM model (R2 = 60.4%)
Intercept 0.2260.10 0.03
AF Burden 22.5260.27 ,0.001
AF Density 1.1160.39 ,0.001
AF Burden2 1.3260.31 ,0.001
To restore normality, the natural logarithm of the required IRM frequency was
regressed. Separate models were fit for the four IRM modalities (24-hour, 7-day,
14-day, and 30-day). SE: standard error, IRM: intermittent rhythm monitor, AF:
atrial fibrillation.
doi:10.1371/journal.pone.0089022.t002
Figure 3. The effect of AF burden and AF density on the probability of AF detection with a single 24-hour IRM (left panel) for the AF
recurrence pattern of two example patients (right panel). For any given AF burden b, observed during any time frame, the probability of
successful identification using a given IRM duration ranges between >b and 1. The range [>b,1] depends on the temporal aggregation of the AF
recurrences (AF density). If the AF occurs as one episode, the probability of AF detection is >b (Patient B), whereas if the AF recurrence is uniformly
spread throughout the observation time the probability of AF recurrence detection is 1 (Patient A). IRM: intermittent rhythm monitor, AF: atrial
fibrillation.
doi:10.1371/journal.pone.0089022.g003
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estimates. For example, as Figure 4 illustrates, a strategy of four
24-hour IRMs would fail to identify 75% of our patient population
with otherwise proven AF recurrence (Figure 4, percentage of
black dots being above and to the left of the 4/year dotted line).
Do longer IRM durations lead to increased AF detection?
In light of the limitation of short duration IRM, longer IRM
durations have been proposed for more accurate AF recurrence
detection. We and others have previously seen that on average,
longer duration IRM indeed results in more accurate AF
recurrence detection [5,6]. However, longer IRM pose two
distinct disadvantages:
First, the benefit of longer IRM is not linear with respect to the
monitoring time. Especially in patients with high density AF,
longer IRM may result in little or no practical benefit in terms of
the probability of AF recurrence detection [5,14]. The efficiency of
longer IRMs diminishes as the monitoring time increases. This is
presented in Figure 8. When considering the monitored days (the
number of days the patient wears the IRM), the 24-hour IRM
achieves higher sensitivities, with less monitoring days than all
Figure 4. Required 24-hour IRM frequency to achieve 80% (left) and 95% (right) probability of AF detection. The black dots represent
our patient population. IRM: intermittent rhythm monitor, AF: atrial fibrillation.
doi:10.1371/journal.pone.0089022.g004
Figure 5. Required 7-day IRM frequency to achieve 80% (left) and 95% (right) probability of AF detection. The black dots represent our
patient population. IRM: intermittent rhythm monitor, AF: atrial fibrillation.
doi:10.1371/journal.pone.0089022.g005
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other prolonged IRM durations. This stems from the fact that an
n-day IRM will only be able to detect AF recurrence taking place
within the n consecutive days from the start of the IRM, whereas,
24-hour IRMs are performed n times at n different time points
during the follow-up period and thus will be able on average to
detect AF recurrence with greater probability. This is especially
important for patients with paroxysmal AF as it has been shown
that paroxysmal AF frequently recurs in clusters (higher AF
density, low AF burdens) [1] thus monitoring for AF at n different
time points is more advantageous than monitoring n consecutive
days.
Second, there is now significant evidence that longer IRM
durations adversely affect patient compliance[12]. Reported
causes of patient non-compliance with scheduled monitoring
include skin irritation, interference with showering or exercise, and
feelings of self-consciousness when wearing the monitoring
equipment in public[19]. A recent study with an external
arrhythmia monitoring patch reported that the device fell off in
22% of patients and resulted in a mean wear time of 7.961.8 days
Figure 6. Required 14-day IRM frequency to achieve 80% (left) and 95% (right) probability of AF detection. The black dots represent
our patient population. IRM: intermittent rhythm monitor, AF: atrial fibrillation.
doi:10.1371/journal.pone.0089022.g006
Figure 7. Required 30-day IRM frequency to achieve 80% (left) and 95% (right) probability of AF detection. The black dots represent
our patient population. IRM: intermittent rhythm monitor, AF: atrial fibrillation.
doi:10.1371/journal.pone.0089022.g007
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instead of the planned 14 days[20]. Kamel at al. reported that
patients randomized to monitoring via mobile cardiac outpatient
telemetry wore the monitors for 64% of the assigned days and that
25% of patients were not compliant at all with the scheduled
monitoring [21]. In another study which utilized the same
monitoring technology in 19 patients who recently underwent
catheter ablation for AF, only 53% of patients complied with the
scheduled monitoring[22]. Shorter, but more frequent IRMs tend
to have much higher patient compliance and may result in better
AF recurrence detection under real life conditions. Additionally,
shorter IRMs performed more frequently may lead to less patient
discomfort and disruption of daily activities.
Intermittent rhythm monitoring in the era of continuous
monitoring
Although an aggressive monitoring strategy of twelve 24-hour
IRM per year may reliably detect the great majority of patients
(83.4% of our patient population, 96.0% of the AF burden/AF
density plane, Figure 3), it should be noted that there is still an
element of chance in this process (80% or 95% probability of AF
detection) and some patients may be misclassified. This seems to
be of importance when designing clinical studies, especially when
the outcome of interest is of low incidence. Furthermore, such
aggressive strategies still require considerable amount of resources
as well as patient compliance and physician commitment.
Continuous monitoring is an attractive alternative to IRM.
Indeed, several studies lately have recently surfaced in which
Figure 8. Time efficiency (sensitivity obtained per monitored day) of IRM strategies. For the same amount of total monitored time, shorter
IRM durations result in higher sensitivities. The dotted and solid horizontal line represents sensitivities of 0.5 and 0.95 respectively. IRM: intermittent
rhythm monitor, AF: atrial fibrillation.
doi:10.1371/journal.pone.0089022.g008
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follow-up of patients usually after therapeutic interventions for AF
is being performed using implantable subcutaneous monitoring
devices or using the readings of intra-cardiac devices capable of
detecting and recording AF recurrence. A great advantage of this
approach is that these devices not only allow much more accurate
AF recurrence detection but also can provide the calculation of
quantitative AF indices (e.g. AF burden) and may allow better
understanding of the AF recurrence dynamics. However, the
implantation of leadless CM requires a minor surgical procedure
which may carry a small risk of infection or patient discomfort.
CM has a higher initial cost, however rhythm disclosure and
reporting can be reported remotely via telemetry and patient visits
can be scheduled on an ‘‘as needed’’ basis [23]. Additionally, the
current generation of implantable leadless CM devices can provide
rhythm disclosure for at least 3 years after implantation, a fact
which may increase the cost efficiency of CM over that period.
Although intra-cardiac and leadless rhythm monitors may fail to
detect or may misclassify a small number of AF episodes, these
erroneous episodes tend to be very brief in duration and therefore
have minimal impact on the overall AF burden measurement.
Several studies have shown that these devices can quantify AF
burden with $98.5% accuracy [4,8].
Nevertheless there is currently no evidence that in patients with
AF, continuous rhythm monitoring can improve patient specific
outcomes compared to IRM. More data are required to evaluate
the impact of CM on patient specific outcomes. However, in the
setting of clinical trials, the complete and accurate rhythm
disclosure that CM devices provide can lead to a more accurate
understanding and scientific evaluation of treatments for AF.
Limitations
Our methodology does not allow and does not take into
consideration patient symptoms which may help guide the AF
follow-up. However, numerous studies have shown that symptoms
have a low sensitivity and specificity [3], which may or may not
lead to better and more reliable AF recurrence detection.
Moreover, for the scientific evaluation of AF treatments even
with the presence of symptoms, and because of their low sensitivity
and specificity, AF recurrence still should be electrocardiograph-
ically documented. Additionally, recent evidence shows that after
invasive AF treatments the ratio of asymptomatic to symptomatic
AF episodes increases [2,12]. Therefore, although a limitation, we
believe that not accounting for patient symptoms does not limit the
validity and applicability of our findings. Additionally, our analysis
assumed 100% patient compliance with all simulated IRM
strategies. In reality, reduced patient compliance with more
intensive external monitoring would further diminish the ability of
IRM to detect AF recurrences.
Conclusion
Reliable AF recurrence detection requires higher IRM
frequencies than currently recommended, especially for patients
with low (,0.5) AF burdens. Current IRM frequency recommen-
dations will fail to identify AF recurrences in a significant – albeit
difficult to prospectively estimate - proportion of patients. Shorter
duration IRM performed more frequently during the follow-up
period are significantly more efficient with respect to time and
probably patient compliance than longer duration IRMs for the
same amount of monitored time. For the scientific evaluation of
AF treatments and confident detection of AF recurrence,
especially in the setting of clinical trials, continuous monitoring
should be considered.
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